 |
|
|
|
March 2001 Cover
|
|
Researchers at the Universidad Nacional Autonoma de Mexico
discovered that highly active antiretroviral therapy (HAART) that
includes a protease inhibitor can reduce the occurrence of
HIV-associated oral lesions by
30 percent. The researchers studied the prevalence of oral lesions in
154 AIDS patients in Malaga, Spain, between 1997 and 1998. Just over
half of the subjects had HIV-related oral lesions, most commonly oral
candidiasis
and hairy leukoplakia. The researchers suggest in the December issue
of AIDS Patient Care and STDs (2000;14:627-635) that the drug regimen
of reverse transcriptase inhibitors and protease inhibitors may have
boosted
the patients' immunologic conditions.
Editor's Note: from Reuters Health Info Services
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
